30.82
30.82 (0%)
As of Feb 14, 2025
Baxter International Inc [BAX]
Source:
Company Overview
Baxter International Inc., through its subsidiaries, provides a broad portfolio of essential healthcare products, including sterile intravenous (IV) solutions; infusion systems and devices; parenteral nutrition therapies; inhaled anesthetics; generic injectable pharmaceuticals; surgical hemostat and sealant products, advanced surgical equipment; smart bed systems; patient monitoring and diagnostic technologies; and respiratory health devices.
| Country | United States |
| Headquarters | deerfield, illinois |
| Phone Number | (224) 948 2000 |
| Industry | manufacturing |
| CEO | Brent Shafer |
| Website | www.baxter.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $10,636 |
| Operating Profit | $14 |
| Net Income | $-638 |
| Net Cash | $-784 |
Profit Ratios
| Gross Margin | $3,984 |
| Operating Margin | 0.1 |
| Profit as % of Revenues | -624.5% |
| Profit as % of Assets | -2.4% |
| Profit as % of Stockholder Equity | -9.1% |
Management Effectiveness
| Return on Equity | -9.1% |
| Return on Assets | -2.5% |
| Turnover Ratio | 39.4% |
| EBITA | $14 |
Balance Sheet and Cash Flow Measures
| Total Assets | $25,782 |
| Total Liabilities | $18,758 |
| Operating Cash Flow | $1,019 |
| Investing Cash Flow | $-626 |
| Financing Cash Flow | $-1,081 |
